Caitlin Moran is an Infectious Disease physician affiliated with Emory University. OpenAlex indexes 61 publications with 718 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
30%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.8%Descovy77%Triumeq23%Part D<11 patientsProtease Inhibitor10.4%Ritonavir42%Prezcobix30%Atazanavir Sulfate27%Part D<11 patients+ 2 more classes in this area
Cardiovascular
26.3%Statin8.3%Atorvastatin Calcium57%Rosuvastatin Calcium43%Part D<11 patientsCalcium channel blocker8.2%Amlodipine Besylate100%Part D≥14 patients+ 2 more classes in this area
Metabolism & gastrointestinal
16%GLP-1 receptor agonist4.6%Victoza 3-Pak100%Part D<11 patientsProton pump inhibitor3.8%Omeprazole54%Esomeprazole Magnesium46%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- HIV and endothelial function in women of reproductive age (HEART)
Emory University
FY2026$783,830R01HL180235 - Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
Emory University
FY2025$551,276R01AR079298 - Predictors of Antiretroviral Immunereconstitution Bone Loss - the Gut and the Microbiome
Emory University
FY2025$55,678R01AR079298
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
Laurence Sperling, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”